U.S. Energy Boom Ke...
Health Care: Drugs
Compugen Ltd. (CGEN: NASDAQ)
$5.44 -0.06 | -1.09%
05/23/13 - 03:59 PM ET
68.30K / 149.10K
Vol / Avg. Vol:5.45 / 5.50
Open / Prev. Close:5.40 - 5.50
Today's Range:2.96 - 6.32
52 Wk Range:11.79%
Performance YTD:TheStreet Rating:
Portfolios with CGEN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Bargain Biotech Stocks
- Userdesignbydiana Portfolio 1
- Userraveha1 Portfolio 1
- ContributorBiotech Short Squeezes
- UserSUPRATRADE-QUANTUM STARDUST 8
- UserHumelor Portfolio 1
Latest CGEN Headlines from TheStreet
- Compugen's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 03:08 pm
- 7 Stocks Under $10 Soaring Higher 05.24.12 | 12:05 pm
- 5 Bargain Biotech Stocks 01.13.11 | 05:01 pm
- Maguire Properties, Compugen: Midday Volume Plays 05.11.10 | 11:05 am
- eOn Communications, Compugen: Early Volume Plays 03.16.10 | 09:03 am
- Pluristem Therapeutics, Compugen: Early Volume Plays 03.02.10 | 09:03 am
- Array BioPharma, Sterling Financial: Early Volume Plays 02.02.10 | 09:02 am
- Biotech's Movers & Shakers 2009: BioBuzz 01.04.10 | 09:01 am
- Compugen, Flotek: Early Volume Plays 01.04.10 | 07:01 am
- China BAK, Compugen: Early Volume Plays 12.30.09 | 08:12 am
Press Releases for CGEN
- Compugen Ltd. Reports Fourth Quarter And Calendar 2012 Financial Results - Business Wire 02.20.13 | 06:02 am
- Compugen Fourth Quarter 2013 Conference Call Scheduled For Wednesday, February 20, 2012 At 10:00 AM EST - Business Wire 02.12.13 | 11:02 am
- Compugen To Present At The Molecular Medicine Tri-Conference 2013 In San Francisco - Business Wire 02.05.13 | 07:02 am
- Compugen Presents At American Association Of Cancer Research Special Conference On Tumor Immunology - Business Wire 12.04.12 | 07:12 am
- Compugen Announces $15 Million Funding Agreement For Its Keddem Subsidiary - Business Wire 11.19.12 | 08:11 am
- Compugen To Present At Jefferies 2012 Global Healthcare Conference - Business Wire 11.14.12 | 07:11 am
- Compugen Ltd. Reports Third Quarter 2012 Financial Results - Business Wire 11.05.12 | 07:11 am
- Compugen Announces Discovery Of Two Novel Immune Checkpoint Targets For Cancer Immunotherapy - Business Wire 10.31.12 | 08:10 am
- Compugen Postpones Issuance Of Third Quarter 2012 Report And Associated Conference Call To November 5, 2012, Due To Expected Severe Weather Conditions - Business Wire 10.29.12 | 10:10 am
- Compugen Third Quarter 2012 Conference Call Scheduled For Tuesday, October 30, 2012 At 10:00 AM EDT - Business Wire 10.23.12 | 07:10 am
Partner Headlines for CGEN
- Show Me The Money: ADC Revenue Payloads Miss The Mark - Seeking Alpha 11.26.12 | 09:11 am
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
- Compugen: On the Road to Breakthroughs - Seeking Alpha 05.12.10 | 03:05 am
